How Do I Sell Medical Devices in Belgium?

To sell medical devices in Belgium, you need CE marking compliance under the EU Medical Device Regulation (MDR), registration with the FAMHP (Federal Agency for Medicines and Health Products), and proper documentation, including technical files and labeling in Dutch, French, or German. Non-EU manufacturers must also appoint a European Authorized Representative. The process typically takes 6–18 months, depending on device classification and market entry strategy.

What Are the Basic Requirements for Selling Medical Devices in Belgium?

Entering the Belgian medical device market requires compliance with several fundamental regulatory requirements that ensure device safety and market access:

• CE marking compliance – Your medical device must carry valid CE marking demonstrating conformity with EU safety and performance requirements, including proper device classification and appropriate conformity assessment procedures.
• Comprehensive technical documentation – Maintain complete technical files, risk management documentation, clinical evidence, and post-market surveillance plans that meet EU MDR standards.
• Multilingual labeling requirements – All labeling and instructions for use must be available in at least one of Belgium’s official languages: Dutch, French, or German.
• FAMHP registration – Register your devices with Belgian health authorities to ensure proper documentation in healthcare databases and enable lifecycle tracking.
• European Authorized Representative – Non-EU manufacturers must designate a qualified representative to serve as the legal contact point with Belgian authorities.
• Post-market compliance systems – Establish systems for incident reporting, field safety corrective actions, and ongoing regulatory obligations throughout the device lifecycle.

These requirements work together to create a comprehensive regulatory framework that protects patient safety while enabling market access. Higher-risk devices require additional oversight through Notified Body involvement, which can significantly impact timelines and complexity. The classification of your device (Class I, IIa, IIb, or III) determines the specific pathway and requirements you must follow, making proper classification a critical first step in your market entry strategy.

How Does the EU Medical Device Regulation Affect Sales in Belgium?

The EU MDR directly governs Belgian medical device law, as Belgium implements EU regulations as national law. The regulation establishes classification systems, conformity assessment procedures, and ongoing compliance obligations that determine your market access timeline and requirements.

Device classification under the EU MDR determines your regulatory pathway. Class I devices (lowest risk) can often be self-certified, while Class IIa, IIb, and III devices require Notified Body involvement. Classification significantly affects timelines: Class I devices might achieve compliance in 3–6 months, while Class III devices can take 12–18 months or longer.

The regulation mandates specific conformity assessment procedures based on your device classification. These procedures include quality management system requirements, technical documentation standards, and clinical evaluation obligations. You must demonstrate not only safety, but also clinical performance and a favorable benefit–risk profile.

Post-market surveillance requirements under the EU MDR include incident reporting, periodic safety update reports, and post-market clinical follow-up where applicable. These ongoing obligations continue throughout your device’s lifecycle in Belgium and require dedicated resources for compliance management.

What’s the Difference Between Direct Sales and Using Distributors in Belgium?

Choosing between direct sales and distributor partnerships significantly impacts your market entry strategy, operational requirements, and long-term business relationships in Belgium:

• Direct sales approach – Provides complete control over marketing messages and customer relationships while requiring establishment of legal presence, regulatory compliance management, and independent handling of logistics and customer service.
• Distributor partnerships – Offers immediate access to established sales networks and local market expertise while involving shared margins and potential loss of direct customer control and insights.
• Operational complexity differences – Direct sales require significant resource investment in local operations, while distributors handle customer relationships, regulatory compliance, and often provide warehousing support.
• Financial considerations – Direct sales typically yield higher profit margins but involve greater upfront investment, whereas distributor relationships reduce operational costs but decrease per-unit profitability.
• Market knowledge access – Distributors bring valuable local market insights and established healthcare relationships, while direct sales require building these relationships independently over time.
• Hybrid strategies – Many companies use distributors for initial market testing while building direct sales capabilities, providing flexibility as market presence grows.

The choice between these approaches depends on your company’s resources, long-term market commitment, and strategic objectives. Companies with sufficient resources and long-term Belgian market commitment often prefer direct sales for maximum control and profitability. However, distributors provide an excellent entry point for testing market demand and building initial presence before committing to direct operations, making them particularly valuable for smaller companies or those entering the Belgian market for the first time.

How Do You Register Medical Devices With the Belgian Health Authorities?

Medical device registration in Belgium involves submitting device information to the FAMHP through the appropriate EU database systems, including EUDAMED for most devices. The process requires valid CE marking, complete technical documentation, and the designation of responsible economic operators.

The registration process typically follows these steps:

• Prepare documentation – Gather CE certificates, technical files, labeling samples, and instructions for use to ensure complete regulatory submission packages.
• Designate economic operators – Identify your Authorized Representative, importers, and distributors while ensuring they meet qualification requirements and understand their responsibilities.
• Submit registration data – Enter device information into EUDAMED or relevant national databases with accurate classification and technical specifications.
• Verify compliance – Ensure all regulatory requirements are met before placing the device on the market, including labeling and post-market surveillance systems.
• Maintain registrations – Update information when changes occur to devices or operators, maintaining current records throughout the device lifecycle.

These registration steps form a sequential process that requires careful attention to detail and completeness at each stage. Registration timelines vary based on device complexity and documentation quality, with simple Class I devices potentially completing registration within 2–4 weeks when all documentation is complete. More complex devices requiring additional verification can extend timelines to 2–3 months, particularly when authorities request additional information or clarification. The FAMHP may request supplementary details during review, especially for higher-risk devices or novel technologies, making prompt and comprehensive responses essential to prevent delays in your Belgian medical device approval timeline.

What Role Does a European Authorized Representative Play in Belgium?

A European Authorized Representative is mandatory for non-EU medical device manufacturers selling in Belgium, serving as your legal contact point with Belgian authorities and ensuring ongoing compliance throughout your device’s lifecycle:

• Regulatory compliance verification – Verifies device registration compliance, maintains copies of technical documentation, and ensures all EU MDR requirements are met before market placement.
• Authority communication – Serves as the primary contact for Belgian healthcare authorities, handles regulatory communications, and cooperates during investigations or compliance reviews.
• Incident management – Forwards incident reports to appropriate authorities, coordinates field safety corrective actions, and manages post-market surveillance obligations.
• Documentation maintenance – Maintains current technical files, certificates, and regulatory correspondence while ensuring accessibility for authority inspections.
• Regulatory monitoring – Tracks changes in Belgian and EU regulations, advises on compliance implications, and helps adapt procedures to new requirements.
• Market continuity – Provides ongoing local presence to maintain good relationships with regulators and ensure uninterrupted market access.

Your Authorized Representative becomes legally liable for ensuring regulatory compliance when your devices are placed on the Belgian market, making their selection critical to your success. They must maintain professional indemnity insurance and demonstrate financial stability to fulfill these obligations. The representative should offer consolidated services across multiple European markets to streamline compliance management while providing dedicated expertise in your specific device types and regulatory requirements.

How Long Does It Typically Take to Enter the Belgian Medical Device Market?

Entering the Belgian medical device market typically takes 6–18 months for most devices, depending on classification, regulatory complexity, and your chosen market strategy. Class I devices with complete documentation might achieve market entry in 6–9 months, while higher-risk devices requiring Notified Body involvement often need 12–18 months.

The timeline can be broken down into several phases:

• Preparation phase (2–6 months) – Device classification, technical documentation development, and quality system implementation to establish regulatory foundation.
• Conformity assessment (3–12 months) – CE marking process, including Notified Body involvement for higher-risk devices and completion of required testing procedures.
• Market setup (1–3 months) – Authorized Representative appointment, distributor selection, and completion of registrations with Belgian authorities.
• Commercial launch (1–2 months) – Final regulatory clearances, marketing preparation, and sales team training to ensure successful market entry.

These phases often overlap and their duration depends heavily on device complexity and preparation quality. Factors that accelerate market access include having complete technical documentation ready, working with experienced regulatory partners, and choosing appropriate market entry strategies. Delays commonly result from incomplete documentation, Notified Body backlogs, or changes in regulatory requirements during the approval process. Planning your Belgian market entry timeline should account for potential delays and seasonal factors that may affect regulatory review processes, while starting early and partnering with experienced regulatory consultants helps ensure smoother market access and reduces unexpected timeline extensions.

How MedEnvoy Global Helps With Belgian Medical Device Market Entry

MedEnvoy Global provides comprehensive In-Country Representation services that streamline your entry into Belgium’s medical device market while maintaining full regulatory compliance. Our integrated approach addresses every aspect of Belgian market access:

• European Authorized Representative services – Serving as your legal representative with Belgian authorities while maintaining technical documentation and handling regulatory communications
• FAMHP registration support – Managing device registrations and database submissions to ensure proper documentation with Belgian health authorities
• Ongoing compliance management – Monitoring regulatory changes, coordinating post-market surveillance obligations, and managing incident reporting requirements
• Multi-market coordination – Providing consolidated regulatory support across European markets to optimize your international compliance strategy
• Local market expertise – Offering insights into Belgian healthcare systems and regulatory expectations to accelerate market access

Ready to enter the Belgian medical device market with confidence? Contact MedEnvoy Global today to discover how our proven In-Country Representation services can eliminate regulatory barriers and accelerate your market entry timeline.

Related Articles

• How much does EUDAMED registration cost?
• What is Regulatory Risk Management in Medical Device Compliance?
• What Are the Requirements to Sell Medical Devices in Mexico?
• What Is Vigilance Reporting for Medical Devices?
• What Is a Swiss Importer vs Swiss Authorized Representative?